Early recognition and timely escalation of care are essential for preventing serious AEs
2-9 They do this by: Building confidence and self-efficacy by empowering patients to actively engage with their treatment journey Educating patients to address the widespread misconception that obesity is not a disease, with 40% of patients unaware of this and 80% feeling solely responsible for their condition Implementing a whole-health approach to redefine treatment success, focus on overall health outcomes, not just weight loss Setting realistic expectations which prepares patients for the possibility of losing less weight than expected while still achieving significant health benefits Supporting medication adherence by providing tools for reminders, routines, titration guidance, and addressing injection anxiety Driving medication persistence as a result of setting realistic expectations and frame treatment around long-term health gains rather than short-term weight loss Mitigating side effects through equipping patients to self-manage common side effects through proactive tracking and helping them connect the dots Want to learn even more about how digital solutions can unlock the full potential of GLP-1 therapies
GLP-1 also seem to act on the reward and satiety centers of the brain (more research is being done on exactly what mechanisms)
Some healthcare providers prescribe split dosing, dividing the weekly amount into two doses given three to four days apart
Spit also cleanses bacteria and helps prevent conditions like cavities and gingivitis
Economically it can also have a major impact
